Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trial.
Ferrari V, Valcamonico F, Amoroso V, Simoncini E, Vassalli L, Marpicati P, Rangoni G, Grisanti S, Tiberio GA, Nodari F, Strina C, Marini G. Ferrari V, et al. Among authors: rangoni g. Cancer Chemother Pharmacol. 2006 Jan;57(2):185-90. doi: 10.1007/s00280-005-0028-1. Epub 2005 Sep 3. Cancer Chemother Pharmacol. 2006. PMID: 16151811 Clinical Trial.
Solitary breast metastases from a renal cell carcinoma.
Vassalli L, Ferrari VD, Simoncini E, Rangoni G, Montini E, Marpicati P, Mambrini A, Pagani M, Agazzi C, Marini G. Vassalli L, et al. Among authors: rangoni g. Breast Cancer Res Treat. 2001 Jul;68(1):29-31. doi: 10.1023/a:1017990625298. Breast Cancer Res Treat. 2001. PMID: 11678306
Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial.
Rosati G, Lonardi S, Galli F, Di Bartolomeo M, Ronzoni M, Zampino MG, Banzi M, Zaniboni A, Pasini F, Bozzarelli S, Garattini SK, Ferrari D, Montesarchio V, Mambrini A, Ciuffreda L, Galli F, Pusceddu V, Carlomagno C, Bidoli P, Amoroso D, Bochicchio AM, Frassineti L, Corsi D, Bilancia D, Pastorino A, De Stefano A, Labianca R; TOSCA (Three or Six Colon Adjuvant) investigators. Rosati G, et al. Eur J Cancer. 2021 May;148:190-201. doi: 10.1016/j.ejca.2021.01.051. Epub 2021 Mar 18. Eur J Cancer. 2021. PMID: 33744715
Panniculitis and vitiligo occurring during BRAF and MEK inhibitors combination in advanced melanoma patients: Potential predictive role of treatment efficacy.
Consoli F, Manganoni AM, Grisanti S, Petrelli F, Venturini M, Rangoni G, Guarneri F, Incardona P, Vermi W, Calzavara Pinton PG, Berruti A. Consoli F, et al. Among authors: rangoni g. PLoS One. 2019 Apr 2;14(4):e0214884. doi: 10.1371/journal.pone.0214884. eCollection 2019. PLoS One. 2019. PMID: 30939167 Free PMC article.
30 results